Quantum-Si Incorporated is a company pioneering next-generation semiconductor chip-based proteomics. Quantum-Si Incorporated, formerly known as HighCape Capital Acquisition Corp., is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $3.06M |
| Net Income (Most Recent Fiscal Year) | $-101.01M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 68.84 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.97 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -3117.58% |
| Net Margin (Trailing 12 Months) | -3120.14% |
| Return on Equity (Trailing 12 Months) | -44.57% |
| Return on Assets (Trailing 12 Months) | -39.45% |
| Current Ratio (Most Recent Fiscal Quarter) | 9.43 |
| Quick Ratio (Most Recent Fiscal Quarter) | 9.27 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 0.39 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.09 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.16 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.66 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.68 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 202.49M |
| Free Float | 141.67M |
| Market Capitalization | $234.89M |
| Average Volume (Last 20 Days) | 7.10M |
| Beta (Past 60 Months) | 2.87 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 30.04% |
| Percentage Held By Institutions (Latest 13F Reports) | 39.90% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |